Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Answering The Vytorin Question
Forbes
Wednesday, November 18, 2009 - 9:02am
tags:
Merck, Zetia, Vytorin, Abbott Laboratories, Niaspan, cholesterol
Crestor Cuts Cardiovascular Problems In Women
WSJ Online
Tuesday, November 17, 2009 - 5:27pm
tags:
AstraZeneca, women, Crestor, statins, JUPITER
Titan Pharmaceuticals: Finally Reaching Its Potential
Seeking Alpha
Tuesday, November 17, 2009 - 5:22pm
tags:
Titan
BioCryst hopes to raise $57M with stock offering
Bizjournals.com
Tuesday, November 17, 2009 - 4:07pm
tags:
Biocryst, stock offering
Oxigene's developing cancer treatment meets safety goals in midstage study
Yahoo/AP
Tuesday, November 17, 2009 - 2:17pm
tags:
Oxigene, drug studies, lung cancer, Zybrestat
Vaccines on horizon for AIDS, Alzheimer's, herpes
Yahoo/AP
Tuesday, November 17, 2009 - 2:16pm
tags:
AIDS, Alzheimer's disease, herpes, vaccines, GSK, Crucell, AstraZeneca
Brilinta bests Plavix in trial
Fierce Biotech
Tuesday, November 17, 2009 - 2:15pm
tags:
Plavix, Brilinta, AstraZeneca, Sanofi, Bristol-Myers Squibb
A Big Upgrade for Sanofi-Aventis
Motley Fool
Tuesday, November 17, 2009 - 11:35am
tags:
Sanofi
Merck dodged Zetia bullet, analysts say
Fierce Pharma
Tuesday, November 17, 2009 - 11:34am
tags:
Zetia, Merck, Abbott Laboratories, Niaspan, cholesterol
Drug-price outcry threatens to derail reform
Fierce Pharma
Tuesday, November 17, 2009 - 11:33am
tags:
healthcare reform, drug prices
Human Genome's ABthrax Faces FDA Delay
Yahoo/Zacks.com
Tuesday, November 17, 2009 - 11:21am
tags:
ABthrax, anthrax, vaccines, FDA, Human Genome Sciences
Alkermes jumps; Cerus, InterMune slide
Marketwatch
Tuesday, November 17, 2009 - 11:20am
tags:
Cerus, InterMune, Alkermes
Isis Cholesterol Drug Effective, but Safety a Worry
TheStreet.com
Tuesday, November 17, 2009 - 11:14am
tags:
Isis Pharmaceuticals, Genzyme, mipomersen
InterMune Hep C Drug Hit With Liver Tox Worry
TheStreet.com
Tuesday, November 17, 2009 - 11:06am
tags:
hepatitis C, InterMune
FDA says Prilosec can block benefits of Plavix
Yahoo/AP
Tuesday, November 17, 2009 - 11:05am
tags:
Prilosec, Plavix, Bristol-Myers Squibb, JNJ, FDA
WuXi Pharma Feels the Worst of the Downturn Is Over
Seeking Alpha
Tuesday, November 17, 2009 - 11:04am
tags:
WuXi PharmaTech, China
AstraZeneca Heartburn Pills Are Tied to Deaths in Artery Clearing
Bloomberg
Tuesday, November 17, 2009 - 11:02am
tags:
Protonix, AstraZeneca
Roche applies for Avastin advanced breast cancer use
Reuters
Tuesday, November 17, 2009 - 10:45am
tags:
Avastin, Roche, breast cancer, Genentech
Novartis: Smaller flu-vaccine doses suffice
Marketwatch
Tuesday, November 17, 2009 - 10:32am
tags:
Flu, vaccines, Novartis, H1N1
As Tax Breaks for Pfizer End, Jobs Disappear
BNET Pharma
Tuesday, November 17, 2009 - 9:56am
tags:
Pfizer, layoffs

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.